Position history for Woodline Partners LP's holdings in PROTAGONIST THERAPEUTICS INC
Woodline Partners LP holds 1.4M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $149.1M as of 2026-Q1. The position was increased (+0.4% shares). PTGX represents 0.6% of Woodline Partners LP's portfolio.
Current Value
$149.1M
Current Shares
1.4M
Total Value Change
+$120.6M
Total Shares Change
+592,000
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc.
Increased |
| 1.4M |
+0.4% |
| $149.1M |
| 0.6% |
| $91.30 |
43 |
| 2025-Q4 | Decreased | 1.4M | -2.0% | $123M | 0.5% | $87.26 | 0 |
| 2025-Q3 | Increased | 1.4M | +51.9% | $95.5M | 0.4% | $65.14 | 50 |
| 2025-Q2 | Increased | 946,884 | +5.5% | $52.3M | 0.3% | $55.69 | 37 |
| 2025-Q1 | Increased | 897,699 | +54.2% | $43.4M | 0.3% | $48.88 | 49 |
| 2024-Q4 | Increased | 582,327 | +24.8% | $22.5M | 0.2% | $38.51 | 42 |
| 2024-Q3 | Decreased | 466,518 | -43.3% | $21M | 0.2% | $44.56 | 0 |
| 2024-Q2 | Increased | 822,173 | +29.1% | $28.5M | 0.3% | $34.65 | 43 |